Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Pharmacological Research|July 31, 2016
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseasesRobert RoskoskiBiochemical and Biophysical Research Communications|March 21, 2007
Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitorRobert RoskoskiBiochemical and Biophysical Research Communications|September 19, 2003
STI-571: an anticancer protein-tyrosine kinase inhibitorRobert RoskoskiPharmacological Research|April 19, 2023
Rule of five violations among the FDA-approved small molecule protein kinase inhibitorsRobert RoskoskiBiochemical and Biophysical Research Communications|December 20, 2011
MEK1/2 dual-specificity protein kinases: structure and regulationRobert RoskoskiPharmacological Research|December 22, 2019
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 updateRobert RoskoskiPharmacological Research|June 1, 2025
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs): A 2025 updateRobert RoskoskiExpert Opinion on Drug Discovery|June 29, 2013
The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disordersRobert RoskoskiPharmacological Research|November 26, 2013
The ErbB/HER family of protein-tyrosine kinases and cancerRobert RoskoskiPageof 7